BusinessBiodesix Announces Biomarker Research Collaboration with Checkmate PharmaceuticalsBy Nasdaq OMXMar 20, 2018, 1:01 PM UTC
BusinessHuge R&D Investments Bodes Well for Cancer Tissue Diagnostics Market - Future Market InsightsBy Nasdaq OMXNov 27, 2017, 10:48 AM UTC
BusinessBiodesix Oral Presentation At SITC: Testing Methodology May Identify Primary Immunotherapy Resistance In PatientsBy Nasdaq OMXNov 7, 2017, 5:22 PM UTC
BusinessOncoMed to Present Data at the American Association of Cancer Research Annual Meeting 2016By Nasdaq OMXMar 16, 2016, 8:30 PM UTC
